Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for > 1 year.
about
Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunctionA review of outcomes of an intracavernosal injection therapy programme.What is the current role of intracavernosal injection in management of erectile dysfunction?Patient preference and satisfaction in decision-making process.
P2860
Preference for oral sildenafil or intracavernosal injection in patients with erectile dysfunction already using intracavernosal injection for > 1 year.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@ast
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@en
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@nl
type
label
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@ast
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@en
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@nl
prefLabel
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@ast
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@en
Preference for oral sildenafil ...... rnosal injection for > 1 year.
@nl
P1433
P1476
Preference for oral sildenafil ...... ernosal injection for > 1 year
@en
P2093
P304
P356
10.1046/J.1464-410X.2003.04324.X
P50
P577
2003-08-01T00:00:00Z